Director of the Rensselaer Polytechnic Institute Center for Biotechnology & Interdisciplinary Studies (CBIS), conducting breakthrough research on bones, Deepak Vashishth, PhD, is working to redefine the role of a top tier research university: one that is engaged in public and private partnerships, involved in interdisciplinary research, and providing quality education, all to drive entrepreneurial, sustainable, socially responsible scientific discovery and technological innovation. Administrative leadership: Through his work as a University Center Director, previously as a School of Engineering Department head, and in professional societies he has successfully developed partnerships, Programs, and platforms, to drive translational scientific research across disciplines, sectors,and geographic boundaries. As Director of CBIS he oversees 70 resident and non-resident faculty (from each of the five Rensselaer Polytechnic Institute schools); engages with global partners in the public, private, and academic sectors; and fosters innovative graduate and undergraduate research and education initiatives. In his first two years as CBIS Director he has: envisioned and facilitated the creation of two transformative research centers (Bioimaging Center and Center for Translational Research in Medicine); led the development of an industry partners program to enhance technology transfer and commercialization; and broadened the scope of interdisciplinary research by combining biotechnology with architecture, humanities, and management. As Department Head of Biomedical Engineering (BME) in the School of Engineering at Rensselaer, in just 3 years he dramatically grew and strengthened the department: increased tenured faculty tenfold (1 to 10); added a senior endowed chair to its rank; and it became home to 7 NSF career awardees and recipient of more than 10 NIH RO1 awards (from 2 in 2009). As a committee member of the Orthopaedic Research Society, he developed and facilitated a “Symposium in Translational Medicine” designed to accelerate the transition of discoveries from lab bench to bedside by bridging the gap between clinical, basic science & engineering, government agencies (FDA) and industry. Research leadership: Dr. Vashishth’s research interests are in the area of biomolecular science and engineering of extracellular matrix with particular emphasis on diagnosis and treatment of osteoporosis and bone tissue engineering. His collaborative, interdisciplinary bone research is redefining how osteoporosis will be diagnosed and treated. In 2012 he was elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE) for contributions to the understanding of how both age and collagen‐modification affect bone fragility (cited over 1000 times). AIMBE fellows represent the top 2% of the medical and biological engineering community in the world and are elected based on nomination and vote by AIMBE fellows (http://aimbe.org/college-of-fellows/cof-1479/). He has opened new avenues for diagnosing and treating osteoporosis by developing a new technique to identify bone proteome from nanoscale samples. The process also has been applied for analyzing precious fossils. He is bringing his breakthrough research to market, co-founding a company (Orthograft plc), to produce the acellular biomimetic grafts for bone repair. Professor Vashishth and his research group have published over 200 peer-reviewed journal publications and conference proceedings in top journals including PNAS, Molecular and Cellular Proteomics, Plos One and others. His work presented in the form of over 100 invited and contributed lectures has been cited as a “New Hope for Osteoporosis Patients” and “Secret Formula for Bone Strength” in mainstream media. Working in collaboration with others, his research group has identified new structural roles for bone proteins and developed new biomimickry-based strategies for tissue engineering scaffolds. In addition to being a Fellow of and active in the AIMBE, he serves as a member of the National Institutes of Health study section on Skeletal Biology and Skeletal Regeneration. He is a board member of the Journal of the Mechanical Behavior of Biomedical Materials and a regular reviewer for other federal and international funding agencies, private foundations and university grants, and journals. He also is a member of the Biomedical Engineering Society, American Society of Bone and Mineral Research and the Orthopaedic Research Society. Educational leadership: Fundamentally focused on education, he is preparing the next generation of researchers and the “faculty of the future” by infusing undergraduate and graduate programs with a more interdisciplinary, collaborative, global perspective on sustainable, translational scientific research. In recognition of his dedication to education, he has won Rensselaer awards for outstanding and innovative classroom teaching including the Class of 1951 Outstanding Teaching award. As CBIS Director, he established new global partnerships, redesigned graduate training programs, and developed a new course, all designed to prepare the “faculty of the future,” focused on sustainable collaborative interdisciplinary research and technology transfer and commercialization. As BME department head (2009-2013): expanded the graduate program three-fold (from 20 to 60 students), attracted more highly qualified graduate students, and promoted early success (National fellowships). He overhauled curriculum, to enhance learning and to improve the undergraduate experience, by reducing class size and providing hands-on education in a technologically connected classroom. Background: He earned his B. Eng with honors from Malaviya National Institute of Technology (India), MS from West Virginia University (USA) and PhD from the University of London (UK). He then conducted post-doctoral research at the Bone and Joint Center, Department of Orthopaedic Surgery, Henry Ford Hospital before joining Rensselaer as an Assistant Professor in Biomedical Engineering in 1999.

Deborah McGuinness is a leading expert in knowledge representation and reasoning languages and systems and has worked in ontology creation and evolution environments for over 20 years. Most recently, McGuinness is best known for her leadership role in semantic web research, and for her work on explanation, trust, and applications of semantic web technology, particularly for scientific applications. “I am interested in making smart systems that help people and machines function better,” said McGuinness. “My slant on this work is to research, develop, and use semantic technologies that allow people and machines to represent, reason with, visualize, and explain information in ways that support understanding and (re)use.   My application areas cover a wide range of domain areas, but often in earth and space science informatics and health informatics.”

Curt Breneman was born in Santa Monica, California in 1956, and went on to earn a B.S. in Chemistry at UCLA in 1980 followed by a Ph.D. in Chemistry at UC Santa Barbara (with an emphasis on Physical Organic and Computational Chemistry) in 1987. Following two years of post-doctoral research at Yale University, Dr. Breneman joined the faculty of the Department of Chemistry at Rensselaer Polytechnic Institute (RPI) and began a program in molecular recognition and computational chemistry based on his concept of "Transferable Atom Equivalents", or TAEs, as building blocks for describing the electronic and reactive character of molecules. Dr. Breneman currently holds the rank of Full Professor in the RPI Department of Chemistry and Chemical Biology, and is the Director of the NIH RECCR Center. He later served as Head of the Department of Chemistry & Chemical Biology and now as Dean of the School of Science. The Breneman research group primarily specializes in the development of new molecular property descriptors and machine learning methods that can be applied to a diverse set of physical and biochemical problems. Of paramount interest are methods that can increase the information content of molecular descriptors, and machine learning techniques that can exploit this data for the creation of fully validated, predictive property models. Current application areas include pharmaceutical ADME prediction, virtual high-throughput screening of drug candidates, protein chromatography modeling (HIC and ion-exchange), as well as polymer property prediction.

Chris Carothers is a Professor in the Computer Science Department at Rensselaer Polytechnic Institute. His research interest are in massively parallel systems focusing on modeling and simulation systems of all sorts. Prof. Carothers is an NSF CAREER award winner and is currently active in the DOE Exascale Co-Design Program associated with designs for next generation exascale storage systems as well as the NSF PetaApps Program, and the Army Research Center's Mobile Network Modeling Institute

I am a Professor in the Department of Computer Science with a courtesy appointment in ECSE Department. I have been serving as the founding Director of Data Science Research Center, and Associated Director of IDEA at Rensselaer Polytechnic Institute (RPI) in Troy, New York. I received MS. and Ph.D. degrees in Computer Science, both from Columbia University , in 1987 and 1994, respectively. Before joining RPI, I was a Member of the Technical Staff at the Bell Laboratories in Murray Hill, New Jersey. My current research interests include applied machine learning in bioinformatics, medical informatics, and cyber security. I am a Fellow of the IEEE, a Senior Member of ACM, and a member of AAA.

Dr. Boleslaw K. Szymanski is the Claire and Roland Schmitt Distinguished Professor at the Department of Computer Science and the Director of the ARL Social and Cognitive Networks Academic Research Center at the Rensselaer Polytechnic Institute. He received his Ph.D. in Computer Science from National Academy of Sciences in Warsaw, Poland, in 1976. Dr. Szymanski published over four hundred scientific articles. He is a foreign member of the National Academy of Science in Poland, an IEEE Fellow and a member of the IEEE Computer Society, and Association for Computing Machinery for which he was National Lecturer. He received the Wiley Distinguished Faculty Award in 2003 and the Wilkes Medal of British Computer Society in 2009. His research interests cover the broad area of network science with current focus on social and computer networks.

Jonathan S. Dordick, Ph.D., is Institute Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, with joint appointments in the Departments of Biomedical Engineering and Biological Sciences.He received his B.A. degree in Biochemistry and Chemistry from Brandeis University and his Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology. At Rensselaer, he served as the Vice President for Research, the Director of the Center for Biotechnology and Interdisciplinary Studies, and Department Chair. He was the founding Co-Director of the Rensselaer-Mount Sinai Center for Engineering and Precision Medicine. Prior to joining Rensselaer, he was Professor of Chemical and Biochemical Engineering at the University of Iowa, where he also served as the founding Associate Director of the Center for Biocatalysis and Bioprocessing. He has served the biochemical engineering community as a previous chairman of the Biotechnology Division of the American Chemical Society and as an editor of Biotechnology & Bioengineering. Dr. Dordick has made foundational contributions to enzyme technology, microscale cell culture engineering, drug discovery and human toxicology, and biomanufacturing. He pioneered the development of enzymatic and chemoenzymatic methods for new materials synthesis, initiated the field of molecular bioprocessing, which combines biocatalytic molecular diversity and in vitro metabolic pathway engineering with high-throughput and high-content microfluidic- and microarray-based tools to generate biologically active compounds, and greatly expanded a fundamental understanding of enzymatic catalysis in abiotic environments critical for chemical and pharmaceutical processing. Finally, he has used biomolecular discovery and engineering to address clinical translation in areas of infectious and neurological diseases, anticoagulant therapy, and highly sensitive point-of-care biosensors based on CRISPR technology. Dr. Dordick has received numerous awards and honors, including election to the National Academy of Engineering and National Academy of Inventors, and receipt of the DIC Award for Excellence in Biochemical Engineering and James E. Bailey Award, both of the Society of Biological Engineering, Amgen Award in Biochemical and Molecular Engineering, AIChE Food, Pharmaceutical and Bioengineering Award, ACS-BIOT Marvin J. Johnson Award, ACS-BIOT Elmer Gaden Award, and International Enzyme Engineering Award. He is Fellow of the American Association for the Advancement of Science, American Chemical Society and the American Institute of Medical and Biological Engineers. Dr. Dordick has cofounded several companies, including EnzyMed, Solidus Biosciences, Inc., Redpin Therapeutics, SynAppBio, and Lavaage, Inc. He has also served on multiple White House-sponsored panels and committees in biomanufacturing. Dr. Dordick has published over 430 papers and is an inventor/co-inventor on over 50 patents and patent applications.

Dr. Ameres returned to RPI after a successful career in industry developing multimedia tools and technology in a number of fields. He has developed groundbreaking MIDI and music software, tools for game developers as well as video and audio compression and streaming technology (including over a dozen patents now held by Google) that has become the format of choice on many of the most popular video platforms on the internet. Ameres completed his M.S. and Ph.D. at RPI while working as Sr Research Engineer at Rensselaer's Experimental Media and Performing Arts Center (EMPAC) where he and collaborators developed "The Campfire", a novel, immersive and interactive visualization system allowing for a unique form of "spatialization" of complex data. He continues to develop applications for The Campfire as an affiliate of Rensselaer's Institute for Data Exploration and Analytics (IDEA). Fun facts: Ameres' family connection to RPI goes back to the class of 1918 and includes 6 alumni of the Institute (so far)! Coincidentally, Ameres' high school best friend is a direct descendent of none other than Stephen Van Rensselaer himself!

James Hendler is the Director of the Future of Computing Institute and the Tetherless World Professor of Computer, Web and Cognitive Sciences at RPI and is also director of the RPI-IBM Artificial Intelligence Research Collaboration.  Hendler is a data scientist with specific interests in open government and scientific data, data science for healthcare, AI and machine learning, semantic data integration and the use of data in government. One of the originators of the Semantic Web, he has authored over 450 books, technical papers, and articles in the areas of Open Data, the Semantic Web, artificial intelligence, and data policy and governance. He is also the former Chief Scientist of the Information Systems Office at the US Defense Advanced Research Projects Agency (DARPA) and was awarded a US Air Force Exceptional Civilian Service Medal in 2002. He is the first computer scientist ever to have served on the Board of Reviewing editors for Science. In 2010, Hendler was selected as an “Internet Web Expert” by the US government and helped in the development and launch of the US data.gov open data website. In 2013, he was appointed as the Open Data Advisor to New York State and in 2015 appointed a member of the US Homeland Security Science and Technology Advisory Committee. In 2016, became a member of the National Academies Board on Research Data and Information, in 2017 a member of the Director’s Advisory Committee of the National Security Directorate of PNNL, and in 2021 became chair of the ACM’s global Technology Policy Council. Hendler is a Fellow of the US National Academy of Public Administration, the AAAI, AAAS, ACM, BCS and IEEE.